RT Journal Article
SR Electronic
A1 Sinclair, Heather Q.
T1 Ziprasidone Therapy in the Acute Depressive Mixed State
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 4
SP 11
OP 11
DO 10.1177/155989771004005
UL http://mdc.sagepub.com/content/10/4/11.abstract
AB Ziprasidone demonstrated efficacy and tolerability among patients with depressive mixed state, according to a recent study. In this double-blind, placebo-controlled, multicenter trial that included 74 patients who met DSM-IV criteria for major depressive disorder and two to three DSM-IV mania criteria, patients were randomized to receive either ziprasidone 40–160 mg/daily (n=36) or placebo (n=38) for 6 weeks in a forced titration regimen.